Aerovate Therapeutics, Inc. (AVTE)
NASDAQ: AVTE · IEX Real-Time Price · USD
1.780
-0.040 (-2.20%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Aerovate Therapeutics Market Cap
Aerovate Therapeutics has a market cap or net worth of $51.30 million as of July 22, 2024. Its market cap has decreased by -87.55% in one year.
Market Cap
51.30M
Enterprise Value
-47.26M
1-Year Change
-87.55%
Ranking
Category
Stock Price
$1.78
Market Cap Chart
Since the IPO on June 30, 2021, Aerovate Therapeutics's market cap has decreased from $323.51M to $51.30M, a decrease of -84.14%. That is a compound annual growth rate of -45.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 51.30M | -91.81% |
| Dec 29, 2023 | 626.10M | -13.15% |
| Dec 30, 2022 | 720.90M | 150.49% |
| Dec 31, 2021 | 287.80M | -11.04% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Barinthus Biotherapeutics | 54.53M |
| LAVA Therapeutics | 54.16M |
| Atara Biotherapeutics | 54.00M |
| Cidara Therapeutics | 53.87M |
| Ocuphire Pharma | 51.59M |
| Inotiv | 50.64M |
| Estrella Immunopharma | 49.84M |
| vTv Therapeutics | 49.63M |